SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021193
Filing Date
2023-05-11
Accepted
2023-05-11 16:03:09
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dice-20230331.htm   iXBRL 10-Q 2210360
2 EX-31.1 dice-ex31_1.htm EX-31.1 21264
3 EX-31.2 dice-ex31_2.htm EX-31.2 20726
4 EX-32.1 dice-ex32_1.htm EX-32.1 12654
5 EX-32.2 dice-ex32_2.htm EX-32.2 12359
  Complete submission text file 0000950170-23-021193.txt   6169672

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dice-20230331_pre.xml EX-101.PRE 189733
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dice-20230331_def.xml EX-101.DEF 111298
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dice-20230331_lab.xml EX-101.LAB 274061
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dice-20230331.xsd EX-101.SCH 28172
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dice-20230331_cal.xml EX-101.CAL 33611
44 EXTRACTED XBRL INSTANCE DOCUMENT dice-20230331_htm.xml XML 940416
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40794 | Film No.: 23910835
SIC: 2834 Pharmaceutical Preparations